Delivery Order SPE2DB25D3108-SPE2DB25FPDQC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count) with a contract ceiling value of $4,393.68. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion on July 23, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Janumet XR 50-1,000 mg tablets in a quantity of 180 units. This delivery order, valued at approximately $39,906, represents a firm fixed-price contract with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,823.85 on August 12, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count). This competitively awarded, firm fixed-price delivery order is expected to be completed by August 13, 2025, with fulfillment occurring at the vendor's location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed among all eligible vendors. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on August 8, 2025, with a ceiling value of $6,644.43 and firm fixed pricing. The contract was competitively awarded with no set-aside designation and is scheduled for completion by August 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) valued at $4,159.32. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract represents a single delivery transaction under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a delivery order valued at $2,658.18 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180-count units). This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of August 18, 2025. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. The contract falls under the...
- The Defense Logistics Agency awarded a $1,913.29 firm fixed price delivery order to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on August 14, 2025, with completion scheduled for August 15, 2025. This non-set-aside competitive award represents a pharmaceutical delivery under the agency's medical supply procurement operations. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal healthcare systems and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JANUMET 50-1,000 mg tablets. The $1,164.33 firm fixed-price contract has an ultimate completion date of March 26, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for providing a comprehensive range of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,417.63 to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on July 29, 2025, with completion scheduled for July 30, 2025. This competitively awarded delivery order, utilizing firm fixed pricing with no set-aside designation, represents pharmaceutical procurement under AmerisourceBergen's broader supply agreement with the federal government. The product will be delivered to the company's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $2,239.56 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 30, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified vendors. This delivery order represents a child...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB25FPDQCDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 12, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count) valued at $3,055.13. This firm fixed-price delivery order is set to be completed by August 13, 2025, and represents a competitive award with no set-aside designation. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. This delivery order exemplifies AmerisourceBergen's role as a critical vendor within the federal medical supply chain, particularly for military and veteran healthcare systems. The company serves as a prime vendor for the Defense Logistics Agency's pharmaceutical procurement needs, supplying a broad range of brand-name and generic medications to support military healthcare programs worldwide. The Janumet delivery reflects the company's capability to fulfill specific pharmaceutical requirements efficiently, contributing to the Defense Health Agency and broader Department of Defense healthcare operations through the established Pharmaceutical Prime Vendor Global Program framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 8/12/25 |